This finding is consistent with a recent single-centre padiatric IBD cohort [29], and the 206 reports of C. difficile infection retrieved from FAERS highlight the need for heightened clinical vigilance in children initiating anti-TNF therapy. This evidence concerns the gene TNF and inflammatory bowel disease.